3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach
暂无分享,去创建一个
Yuhong Xiang | Zhuoyong Zhang | Liying An | Wenxiang Hu | Zhuoyong Zhang | Yuhong Xiang | W. Hu | Liying An
[1] Michael R. Braden,et al. C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. , 2006, Journal of medicinal chemistry.
[2] Peter A. Kollman,et al. PHOTOELECTRON SPECTRA OF PSYCHOTROPIC DRUGS. 6. RELATIONSHIPS BETWEEN PHYSICAL PROPERTIES AND PHARMACOLOGICAL ACTIONS OF AMPHETAMINE ANALOGS , 1982 .
[3] Milica Mišić-Vuković,et al. Investigation of electronic effects in the pyridine and pyridine N-oxide rings. Part 3. Reactions of substituted 2-carboxypyridine N-oxides with diazodiphenylmethane , 1979 .
[4] Martin P Paulus,et al. Effects of Hallucinogens on Locomotor and Investigatory Activity and Patterns: Influence of 5-HT2A and 5-HT2C Receptors , 1998, Neuropsychopharmacology.
[5] James J. Chambers,et al. A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor , 2002, J. Comput. Aided Mol. Des..
[6] P A Kollman,et al. Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues. , 1981, Journal of medicinal chemistry.
[7] D E Nichols,et al. A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. , 1998, Journal of medicinal chemistry.
[8] B W Clare,et al. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters. , 1990, Journal of medicinal chemistry.
[9] P Pauling,et al. Anticholinergic substances: A single consistent conformation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[10] Angelo Vedani,et al. Quasi‐atomistic Receptor Surrogates for the 5‐HT2A Receptor: A 3D‐QSAR Study on Hallucinogenic Substances , 1999 .
[11] Minghu Song,et al. Three-dimensional quantitative structure-activity relationship analyses of piperidine-based CCR5 receptor antagonists. , 2004, Bioorganic & medicinal chemistry.
[12] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[13] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[14] Satya P. Gupta,et al. QSAR studies on hallucinogens , 1983 .
[15] Brian W. Clare,et al. QSAR of benzene derivatives: comparison of classical descriptors, quantum theoretic parameters and flip regression, exemplified by phenylalkylamine hallucinogens , 2002, J. Comput. Aided Mol. Des..
[16] D E Nichols,et al. Structure-activity relationships of phenethylamine hallucinogens. , 1981, Journal of pharmaceutical sciences.
[17] R. Glennon,et al. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane. , 1982, Journal of medicinal chemistry.
[18] Olga Kennard,et al. Crystal and molecular structure of the psychotropic drug 2-(4-ethyl-2,5-dimethoxyphenyl)-1-methylethylamine (4-ethyl-2,5-dimethoxyamphetamine) , 1974 .